How much funding has Surrozen raised?

Surrozen has raised $133.0M in total funding, most recently a Series C round.

Who are Surrozen's investors?

Surrozen's investors include The Column Group, Venrock.

Where is Surrozen headquartered?

Surrozen is headquartered in South San Francisco, California, United States.

What industry is Surrozen in?

Surrozen operates in Biotech, Healthcare, Therapeutics.

Surrozen

IPO

Restoring Vision Through the Science of Renewal

Public · South San Francisco, United States · Founded 2016 · $133.0M raised

Biotech

Healthcare

Therapeutics

Headquarters: South San Francisco, California
Employees: 11–50
Founded: 2016
Business Model: B2B
Website: surrozen.com

Total Funding: $133.0M
Last Round: $50.0M Series CJun 2020
Rounds: 3
Type: Public

About

Surrozen is a clinical-stage biotechnology company pioneering Wnt-based therapeutics designed to repair and restore tissue function. The company's multifunctional biologics selectively activate Wnt signaling for ophthalmic diseases including diabetic macular edema, wet age-related macular degeneration, and uveitic macular edema. Founded in 2016, Surrozen focuses on helping patients preserve and regain vision through its regenerative medicine platform.

Summary

Surrozen is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $133.0M in total across 3 rounds, most recently a $50.0M Series C round in Jun 2020. Investors include The Column Group and Venrock.

LinkedIn X (Twitter)